OPHTHALMIC COMPOSITION COMPRISING CASTOR OIL AND A MEDIUM-CHAIN ​​TRIGLYCERIDE

MA42197AUndetermined Publication Date: 2018-01-10LAB SALVAT SA
0 Cites 0 Cited by

Patent Information

Application Number
MA42197
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Filing Date
2016-07-07
Publication Date
2018-01-10
Patent Text Reader

Abstract

The present invention relates to a sterile ophthalmic composition comprising castor oil and a medium-chain triglyceride, intended for use in medicine, particularly for the treatment and / or prevention of an ocular disease selected from the group consisting of dry eye, conjunctivitis, dermatitis, blepharitis, entropion, dislocating eyelid syndrome, thyroid ophthalmopathy, pterygium, conjunctivochalosis, preservative-induced epithelial lesions, anterior chamber or epithelial lesions induced by ocular surgery, limbal cell deficiency, corneal ulcers induced by physical or chemical agents, keratitis, and uveitis.
Need to check novelty before this filing date? Find Prior Art